Spacelabs Healthcare announced that it has acquired predictive analytics company PeraHealth. Founded in 2010, PeraHealth develops predictive enterprise software based on the Rothman Index, a score to quantify patient acuity. PeraHealth’s solutions alert clinicians to patient deterioration, helping to reduce in-hospital mortality, unplanned transfers to the ICU, and to drive more timely palliative care consults. PeraHealth’s Rothman Index is the only FDA-cleared predictive analytics solution of its kind on the market today.
The Spacelabs team will continue the journey that the Rothman brothers and PeraHealth started more than 10 years ago to provide clinicians with a visual dashboard of the patient’s condition in real-time, helping them to detect changes before they become life-threatening.
“Our mission at Spacelabs is to empower care teams to achieve superior outcomes by providing seamless, high-quality actionable insights,” said Spacelabs President Shalabh Chandra. “By integrating PeraHealth’s powerful analytics into Spacelabs’ digital health portfolio, we can help healthcare organizations deliver better outcomes and decrease costs with a clearer picture of their patients’ health.”
“The alignment of our vision with that of Spacelabs is remarkable,” said Joseph Beals, PhD, former CEO of PeraHealth, who will lead Spacelabs’ data science strategy after the acquisition. “We are confident that Spacelabs will build on the success of PeraHealth’s solutions to further improve patient care, and together we will write the next chapter in digital health innovation.”